Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Current Taxes (2024 - 2025)

Theravance Biopharma (TBPH) has disclosed Current Taxes for 3 consecutive years, with $4.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Taxes changed N/A to $4.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.1 million, a N/A change, with the full-year FY2024 number at $5.9 million, changed N/A from a year prior.
  • Current Taxes was $4.1 million for Q3 2025 at Theravance Biopharma, down from $26.7 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $26.7 million in Q2 2025 to a low of $4.1 million in Q3 2025.